Inventor
GERALD CHRISTOPHE P G
US22 patents
⚠️ This page may combine multiple inventors who share the name “GERALD CHRISTOPHE P G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SYNAPTIC PHARMA CORP
14 patentsUS5989920ANov 23, 1999
Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5
SYNAPTIC PHARMA CORP51 citations96
US5968819AOct 19, 1999
DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
SYNAPTIC PHARMA CORP38 citations96
US5602024AFeb 11, 1997
DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof
SYNAPTIC PHARMA CORP60 citations96
US6368812B1Apr 9, 2002
Process for determining the agonist or antagonist of galanin receptor (GALR3)
SYNAPTIC PHARMA CORP17 citations92
US6316203B1Nov 13, 2001
Methods of screening and preparing a composition using DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
SYNAPTIC PHARMA CORP28 citations92
US6287788B1Sep 11, 2001
DNA encoding galanin GALR3 receptors and uses thereof
SYNAPTIC PHARMA CORP18 citations92
US6262246B1Jul 17, 2001
DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof
SYNAPTIC PHARMA CORP15 citations92
US5972624AOct 26, 1999
Method of identifying ligands which bind recombinant galanin receptor (GALR2)
SYNAPTIC PHARMA CORP32 citations91
US6645774B1Nov 11, 2003
Methods of modifying feeding behavior using compounds with afinity for the human hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
SYNAPTIC PHARMA CORP13 citations84
US6709831B1Mar 23, 2004
DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
SYNAPTIC PHARMA CORP8 citations72
US6586191B2Jul 1, 2003
Method of identifying compounds that bind galanin receptor (GALR2)
SYNAPTIC PHARMA CORP4 citations72
US6818445B2Nov 16, 2004
Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
SYNAPTIC PHARMA CORP2 citations63
US6790656B1Sep 14, 2004
DNA encoding galanin GALR2 receptors
SYNAPTIC PHARMA CORP1 citations61
US6713265B1Mar 30, 2004
Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
SYNAPTIC PHARMA CORP1 citations52
LUNDBECK & CO AS H
8 patentsUS7022489B2Apr 4, 2006
Method of using cells expressing galanin receptor 3 (GALR3)
LUNDBECK & CO AS H3 citations62
US6849727B1Feb 1, 2005
DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
LUNDBECK & CO AS H2 citations61
US7276339B2Oct 2, 2007
DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
LUNDBECK & CO AS H0 citations51
US7252945B2Aug 7, 2007
DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
LUNDBECK & CO AS H0 citations51
US7132248B2Nov 7, 2006
Uses of galanin GALR2 receptors
LUNDBECK & CO AS H0 citations51
US7060449B2Jun 13, 2006
Method of preparing GALR2 receptors composition
LUNDBECK & CO AS H0 citations51
US7041461B2May 9, 2006
Methods of identifying agonists and antagonists of mammalian NPFF receptor
LUNDBECK & CO AS H0 citations51
US7067277B1Jun 27, 2006
Chimeric G proteins and uses thereof
LUNDBECK & CO AS H0 citations48